Christina Yarrington

I am a maternal fetal medicine specialist at Boston Medical Center. I am also the director of Labor and Delivery and the division director for Maternal Fetal Medicine. In my clinical work I care for patients with complications during their pregnancy or after delivery. I am also actively involved in elevating innovation in obstetric care. I recently implemented a program equipping women at risk for hypertensive morbidity postpartum with a cell enabled blood pressure cuff. As they check their BP once a day, at a time in the hectic early days of newborn parenting that best represents their health, my team of nurses reviews their data and reaches out to screen for symptoms and/or start medications according to my algorithm. This work has elevated our ascertainment of BP in the early weeks postpartum – a time of highest risk for stroke – to over 95%. Additionally, equipped and empowered to check and interpret their own blood pressures, women have presented for care and intervention earlier than prior to the program, offering the opportunity to intervene before hypertensive crisis.

My research focuses on postpartum hypertension as it relates to two related fields: 1.) cardiovascular health across the lifespan and 2.) health inequities. I am supported by the NIH and HHS in my research on postpartum blood pressure trajectories and predictive value in relation to events of SMM in the first year postpartum. This work is further enriched by a qualitative limb that examines patient attitudes, acceptability, and self-efficacy via semistructured patient interviews. The latter work is fueled by BMC’s Health Equity Accelerator. Enabled by resources within the hospital and supported by generous donors, I am leading a team to implement technology, patient feedback, and targeted QI interventions to address our internal inequitable outcomes attributable to preeclampsia.

Education

• Boston University School of Medicine, MD
• Harvard Divinity School, MTS
• Oberlin College, BA

Publications

PUBLISHED ON 1/6/2022
* Murray Horwitz ME, Fisher MA, Prifti CA, Rich-Edwards JW, Yarrington CD, White KO, Battaglia TA. Primary Care-Based Cardiovascular Disease Risk Management After Adverse Pregnancy Outcomes: a Narrative Review. J Gen Intern Med. 2022 Jan 06. PMID: 34993867.

PUBLISHED ON 10/30/2021
* Boateng JO, Wachman EM, Turcinovic J, Devera J, Jain M, Jean-Sicard S, Woodard E, Cruikshank A, Sinha B, Bartolome R, Barnett ED, Parker MG, Yarrington C, Connor JH, Taglauer E, Sabharwal V. SARS-CoV-2 in infant urine and fecal samples after in utero COVID-19 exposure. Pediatr Res. 2021 Oct 30. PMID: 34718351.

PUBLISHED ON 9/29/2021
* Deck GM, Yarrington CD, Pennell PB. Factors associated with anti-seizure medication utilization for eclamptic seizures: 1995-2015. Epilepsy Behav. 2021 Sep 29; 124:108299. PMID: 34600278.

PUBLISHED ON 8/23/2021
* Adegoke TM, Pinder LF, Ndiwane N, Parker SE, Vragovic O, Yarrington CD. Inequities in Adverse Maternal and Perinatal Outcomes: The Effect of Maternal Race and Nativity. Matern Child Health J. 2021 Aug 23. PMID: 34424456.

PUBLISHED ON 8/19/2021
* Yarrington CD, Smith-Lin C, Neuhalfen R, Hanchate A, Connors P, Wang C. Racial and ethnic differences in uptake of cell-free fetal DNA aneuploidy screening in an urban safety net hospital. Prenat Diagn. 2021 Oct; 41(11):1389-1394. PMID: 34369603.

PUBLISHED ON 4/14/2021
* Sabharwal V, Bartolome R, Hassan SA, Levesque BM, Camelo IY, Wachman EM, Figueira M, Yarrington CD, Cooper ER, Barnett ED, Parker MG. Mother-Infant Dyads with COVID-19 at an Urban, Safety-Net Hospital: Clinical Manifestations and Birth Outcomes. Am J Perinatol. 2021 06; 38(7):741-746. PMID: 33853145.

PUBLISHED ON 3/29/2021
* DiLorenzo MA, O'Connor SK, Ezekwesili C, Sampath S, Zhao M, Yarrington C, Pierre C. COVID-19 guidelines for pregnant women and new mothers: A systematic evidence review. Int J Gynaecol Obstet. 2021 Jun; 153(3):373-382. PMID: 33660854.

PUBLISHED ON 3/8/2021
* McCloskey L, Bernstein J, The Bridging The Chasm Collaborative, Amutah-Onukagha N, Anthony J, Barger M, Belanoff C, Bennett T, Bird CE, Bolds D, Brenna BW, Carter R, Celi A, Chachere B, Crear-Perry J, Crossno C, Cruz-Davis A, Damus K, Dangel A, Depina Z, Deroze P, Dieujuste C, Dude A, Edmonds J, Enquobahrie D, Eromosele E, Ferranti E, Fitzmaurice M, Gebel C, Blount LG, Greiner A, Gullo S, Haddad A, Hall N, Handler A, Headen I, Heelan-Fancher L, Hernandez T, Johnson K, Jones E, Jones N, Klaman S, Lund B, Mallampalli M, Marcelin L, Marshall C, Maynard B, McCage S, Mitchell S, Molina R, Montasir S, Nicklas J, Northrup A, Norton A, Oparaeke E, Ramos A, Rericha S, Rios E, Bloch JR, Ryan C, Sarfaty S, Seely E, Souter V, Spain M, Spires R, Theberge S, Thompson T, Wachman M, Yarrington T, Yee LM, Zera C, Clayton J, Lachance C. Bridging the Chasm between Pregnancy and Health over the Life Course: A National Agenda for Research and Action. Womens Health Issues. 2021 May-Jun; 31(3):204-218. PMID: 33707142.

PUBLISHED ON 2/26/2021
* Mahoney West H, Milliren CE, Vragovic O, Köhler JR, Yarrington C. Perceived barriers to Chagas disease screening among a diverse group of prenatal care providers. PLoS One. 2021; 16(2):e0246783. PMID: 33635887.

PUBLISHED ON 1/8/2021
* Benarroch Y, Juttukonda L, Sabharwal V, Boateng J, Khan AR, Yarrington C, Wachman EM, Taglauer E. Differential Expression of Rab5 and Rab7 Small GTPase Proteins in Placental Tissues From Pregnancies Affected by Maternal Coronavirus Disease 2019. Clin Ther. 2021 02; 43(2):308-318. PMID: 33541739.